Smith Stan 4
4 · MAIA Biotechnology, Inc. · Filed May 12, 2025
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
2025-05-08$1.50/sh+66,666$99,999→ 1,271,726 total(indirect: See Footnote) - Purchase
Warrants
2025-05-08$2.05/sh+66,666$136,665→ 66,666 total(indirect: See Footnote)Exercise: $2.05From: 2026-05-08Exp: 2031-05-08→ Common Stock (66,666 underlying)
Footnotes (4)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 8, 2025.
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.
- [F4]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.